Verona Pharma to Present at 44th Annual Canaccord Growth Conference
Verona Pharma (Nasdaq: VRNA) has announced its participation in the 44th Annual Canaccord Growth Conference. The company's senior management will present a company overview on Tuesday, August 13, 2024, at 1:30 p.m. EDT / 6:30 p.m. BST.
Investors and interested parties can access a webcast of the event through the Events and Presentations link on the Investors page of Verona Pharma's website, www.veronapharma.com. This presentation provides an opportunity for the company to showcase its progress and future plans to a wider audience of potential investors and industry professionals.
For those seeking additional information, Verona Pharma has provided contact details for investor relations, US investor enquiries, and international/US media enquiries.
Verona Pharma (Nasdaq: VRNA) ha annunciato la sua partecipazione alla 44ª Conferenza Annuale di Crescita Canaccord. Il senior management dell'azienda presenterà una panoramica della società martedì 13 agosto 2024, alle 13:30 EDT / 18:30 BST.
Investitori e parti interessate possono accedere a un webcast dell'evento tramite il link Eventi e Presentazioni nella pagina Investitori del sito web di Verona Pharma, www.veronapharma.com. Questa presentazione offre l'opportunità all'azienda di mostrare i propri progressi e piani futuri a un pubblico più ampio di potenziali investitori e professionisti del settore.
Per coloro che cercano ulteriori informazioni, Verona Pharma ha fornito i contatti per le relazioni con gli investitori, le richieste di investitori statunitensi e le richieste dei media internazionali/statunitensi.
Verona Pharma (Nasdaq: VRNA) ha anunciado su participación en la 44ª Conferencia Anual de Crecimiento de Canaccord. La alta dirección de la empresa presentará una visión general de la compañía el martes 13 de agosto de 2024, a las 1:30 p.m. EDT / 6:30 p.m. BST.
Los inversores y partes interesadas pueden acceder a un webcast del evento a través del enlace de Eventos y Presentaciones en la página de Inversores del sitio web de Verona Pharma, www.veronapharma.com. Esta presentación brinda la oportunidad a la empresa de mostrar su progreso y planes futuros a una audiencia más amplia de posibles inversores y profesionales de la industria.
Para aquellos que buscan información adicional, Verona Pharma ha proporcionado detalles de contacto para relaciones con inversores, consultas de inversores de EE. UU. y consultas de medios internacionales/EE. UU.
Verona Pharma (Nasdaq: VRNA)는 제44회 Annual Canaccord Growth Conference에 참가한다고 발표했습니다. 회사의 고위 경영진은 2024년 8월 13일 화요일 오후 1:30 EDT / 오후 6:30 BST에 회사 개요를 발표할 예정입니다.
투자자 및 이해관계자는 Verona Pharma 웹사이트의 투자자 페이지에 있는 이벤트 및 프레젠테이션 링크를 통해 이벤트의 웹캐스트에 액세스할 수 있습니다, www.veronapharma.com. 이 프레젠테이션은 회사가 잠재적 투자자 및 산업 전문가의 더 넓은 청중에게 진행 상황과 향후 계획을 보여주는 기회를 제공합니다.
추가 정보를 찾고 있는 경우, Verona Pharma는 투자자 관계, 미국 투자자 문의 및 국제/미국 언론 문의에 대한 연락처 세부정보를 제공했습니다.
Verona Pharma (Nasdaq: VRNA) a annoncé sa participation à la 44e Conférence Annuelle de Croissance de Canaccord. La direction supérieure de l'entreprise présentera un aperçu de la société le mardi 13 août 2024, à 13h30 EDT / 18h30 BST.
Les investisseurs et les parties intéressées peuvent accéder à un webcast de l'événement via le lien Événements et Présentations sur la page Investisseurs du site de Verona Pharma, www.veronapharma.com. Cette présentation offre à l'entreprise l'occasion de mettre en avant ses progrès et ses projets futurs à un large public d'investisseurs potentiels et de professionnels du secteur.
Pour ceux qui recherchent des informations supplémentaires, Verona Pharma a fourni les coordonnées pour les relations avec les investisseurs, les demandes d'investisseurs américains et les demandes des médias internationaux/US.
Verona Pharma (Nasdaq: VRNA) hat seine Teilnahme an der 44. Jahreskonferenz von Canaccord bekannt gegeben. Das Senior Management des Unternehmens wird am Dienstag, den 13. August 2024, um 13:30 Uhr EDT / 18:30 Uhr BST eine Unternehmensübersicht präsentieren.
Investoren und interessierte Parteien können über den Link Veranstaltungen und Präsentationen auf der Investoren-Seite der Verona Pharma-Website, www.veronapharma.com, auf ein Webcast der Veranstaltung zugreifen. Diese Präsentation bietet dem Unternehmen die Möglichkeit, seine Fortschritte und zukünftigen Pläne einem breiteren Publikum potenzieller Investoren und Fachleute der Branche vorzustellen.
Für weitere Informationen hat Verona Pharma Kontaktdaten für die Investor Relations, Anfragen von US-Investoren sowie internationale/US-Medienanfragen bereitgestellt.
- None.
- None.
LONDON and RALEIGH, N.C., July 30, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that senior management will present a company overview at the 44th Annual Canaccord Growth Conference on Tuesday, August 13, 2024, at 1:30 p.m. EDT / 6:30 p.m. BST.
A webcast of the event will be available on the Events and Presentations link on the Investors page of the Company’s website, www.veronapharma.com.
For further information please contact:
| Verona Pharma plc | Tel: +1-844-341-9901 |
| Victoria Stewart, Senior Director of Investor Relations and Communications | IR@veronapharma.com |
| Argot Partners (US Investor Enquiries) | Tel: +1-212-600-1902 verona@argotpartners.com |
| Ten Bridge Communications International / US Media Enquiries | Tel: +1-312-523-5016 tbcverona@tenbridgecommunications.com |
| Leslie Humbel |
About Verona Pharma
Verona Pharma is a biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of chronic respiratory diseases with significant unmet medical needs. OhtuvayreTM (ensifentrine) is the Company’s first commercial product and the first inhaled therapy for the maintenance treatment of COPD that combines bronchodilator and non-steroidal anti-inflammatory activities in one molecule. Ensifentrine has potential applications in non-cystic fibrosis bronchiectasis, cystic fibrosis, asthma and other respiratory diseases. For more information, please visit www.veronapharma.com.
FAQ
When is Verona Pharma (VRNA) presenting at the Canaccord Growth Conference?
How can investors watch Verona Pharma's (VRNA) presentation at the Canaccord conference?
What is the purpose of Verona Pharma's (VRNA) participation in the Canaccord Growth Conference?
Who should I contact for investor relations inquiries about Verona Pharma (VRNA)?
